{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:52:22Z","timestamp":1790934742755,"version":"4.1.0"},"reference-count":70,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2012,1,12]],"date-time":"2012-01-12T00:00:00Z","timestamp":1326326400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1002487","type":"journal-article","created":{"date-parts":[[2012,1,12]],"date-time":"2012-01-12T22:09:47Z","timestamp":1326406187000},"page":"e1002487","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":48,"title":["Two-Drug Antimicrobial Chemotherapy: A Mathematical Model and Experiments with Mycobacterium marinum"],"prefix":"10.1371","volume":"8","author":[{"given":"Peter","family":"Ankomah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce R.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,1,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/bmj.2.4582.769","article-title":"Streptomycin treatment of pulmonary tuberculosis.","volume":"2","year":"1948","journal-title":"Br Med J"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/bmj.2.4688.1073","article-title":"Treatment of pulmonary tuberculosis with streptomycin and para-aminosalicylic acid; a Medical Research Council investigation.","volume":"2","year":"1950","journal-title":"Br Med J"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/bmj.1.4769.1157","article-title":"Prevention of streptomycin resistance by combined chemotherapy; a Medical Research Council Investigation.","volume":"1","year":"1952","journal-title":"Br Med J"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1136\/bmj.2.4844.1005","article-title":"Isoniazid in combination with streptomycin or with P.A.S. in the treatment of pulmonary tuberculosis; fifth report to the Medical Research Council by their Tuberculosis Chemotherapy Trials Committee.","volume":"2","year":"1953","journal-title":"Br Med J"},{"key":"ref5","article-title":"Global tuberculosis control - epidemiology, strategy, financing.","year":"2010"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrmicro862","article-title":"Antimicrobial pharmacodynamics: critical interactions of \u2018bug and drug\u2019.","volume":"2","author":"GL Drusano","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1086\/510079","article-title":"Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it's not just for mice anymore.","volume":"44","author":"PG Ambrose","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1198-743x.2001.00295.x","article-title":"Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters.","volume":"7","author":"MR Jacobs","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.","volume":"26","author":"WA Craig","year":"1998","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1086\/424849","article-title":"Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling.","volume":"190","author":"T Gumbo","year":"2004","journal-title":"J Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1128\/AAC.49.8.3178-3181.2005","article-title":"Pharmacodynamic evidence that ciprofloxacin failure against tuberculosis is not due to poor microbial kill but to rapid emergence of resistance.","volume":"49","author":"T Gumbo","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1128\/AAC.00414-06","article-title":"Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy.","volume":"51","author":"RK Shandil","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1128\/AAC.01681-08","article-title":"Pharmacokinetics-pharmacodynamics of pyrazinamide in a novel in vitro model of tuberculosis for sterilizing effect: a paradigm for faster assessment of new antituberculosis drugs.","volume":"53","author":"T Gumbo","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1128\/AAC.00185-07","article-title":"Isoniazid bactericidal activity and resistance emergence: integrating pharmacodynamics and pharmacogenomics to predict efficacy in different ethnic populations.","volume":"51","author":"T Gumbo","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1128\/AAC.48.8.2951-2957.2004","article-title":"Isoniazid pharmacokinetics-pharmacodynamics in an aerosol infection model of tuberculosis.","volume":"48","author":"R Jayaram","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1128\/AAC.01474-06","article-title":"Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears.","volume":"51","author":"AH Diacon","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1128\/AAC.47.7.2118-2124.2003","article-title":"Pharmacokinetics-pharmacodynamics of rifampin in an aerosol infection model of tuberculosis.","volume":"47","author":"R Jayaram","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1128\/AAC.01533-06","article-title":"Concentration-dependent Mycobacterium tuberculosis killing and prevention of resistance by rifampin.","volume":"51","author":"T Gumbo","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1128\/AAC.00461-07","article-title":"Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorption.","volume":"52","author":"JJ Wilkins","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nature05685","article-title":"Antibiotic interactions that select against resistance.","volume":"446","author":"R Chait","year":"2007","journal-title":"Nature"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"14918","DOI":"10.1073\/pnas.0800944105","article-title":"Drug interactions modulate the potential for evolution of resistance.","volume":"105","author":"JB Michel","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"13977","DOI":"10.1073\/pnas.0805965105","article-title":"Accelerated evolution of resistance in multidrug environments.","volume":"105","author":"M Hegreness","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","article-title":"The toxicity of poisons applied jointly.","volume":"26","author":"CI Bliss","year":"1939","journal-title":"Ann Appl Biol"},{"key":"ref24","article-title":"Die quantitation probleme der pharmakologie.","volume":"47\u2013187","author":"S Loewe","year":"1928","journal-title":"Ergeb Physiol 27:"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0031-6997(25)06847-4","article-title":"The search for synergy: a critical review from a response surface perspective.","volume":"47","author":"WR Greco","year":"1995","journal-title":"Pharmacol Rev"},{"key":"ref26","first-page":"5318","article-title":"Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-beta-D-arabinofuranosylcytosine.","volume":"50","author":"WR Greco","year":"1990","journal-title":"Cancer Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1086\/651024","article-title":"Quantitative assessment of combination antimicrobial therapy against multidrug-resistant bacteria in a murine pneumonia model.","volume":"201","author":"Z Yuan","year":"2010","journal-title":"J Infect Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1128\/AAC.48.11.4315-4321.2004","article-title":"Novel approach to characterization of combined pharmacodynamic effects of antimicrobial agents.","volume":"48","author":"VH Tam","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-2999(02)02920-5","article-title":"Enhancement of antinociception by co-administration of an opioid drug (morphine) and a preferential cyclooxygenase-2 inhibitor (rofecoxib) in rats.","volume":"460","author":"M Deciga-Campos","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0022-3565(24)37575-5","article-title":"Species- and gender-related differences in cyclosporine\/prednisolone\/sirolimus interactions in whole blood lymphocyte proliferation assays.","volume":"286","author":"GM Ferron","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.0013-9580.2004.50503.x","article-title":"Pharmacodynamic analysis of the anticonvulsant effects of tiagabine and lamotrigine in combination in the rat.","volume":"45","author":"DM Jonker","year":"2004","journal-title":"Epilepsia"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1128\/AAC.00873-06","article-title":"Concentration-dependent synergy and antagonism within a triple antifungal drug combination against Aspergillus species: analysis by a new response surface model.","volume":"51","author":"J Meletiadis","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1128\/AAC.01309-07","article-title":"Quantitative assessment of combination antimicrobial therapy against multidrug-resistant Acinetobacter baumannii.","volume":"52","author":"TP Lim","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1128\/IAI.65.2.767-773.1997","article-title":"Mycobacterium marinum causes both long-term subclinical infection and acute disease in the leopard frog (Rana pipiens).","volume":"65","author":"L Ramakrishnan","year":"1997","journal-title":"Infect Immun"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1128\/IAI.00887-06","article-title":"Mycobacterium marinum infection of adult zebrafish causes caseating granulomatous tuberculosis and is moderated by adaptive immunity.","volume":"74","author":"LE Swaim","year":"2006","journal-title":"Infect Immun"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1101\/gr.075069.107","article-title":"Insights from the complete genome sequence of Mycobacterium marinum on the evolution of Mycobacterium tuberculosis.","volume":"18","author":"TP Stinear","year":"2008","journal-title":"Genome Res"},{"key":"ref37","article-title":"Performance Standards for Antimicrobial Susceptibility Testing.","author":"CLSI","year":"2005"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1378\/chest.76.6.771","article-title":"Basic mechanisms of chemotherapy.","volume":"76","author":"DA Mitchison","year":"1979","journal-title":"Chest"},{"key":"ref39","first-page":"187","article-title":"Population dynamics of tuberculosis treatment: mathematical models of the roles of non-compliance and bacterial heterogeneity in the evolution of drug resistance.","volume":"2","author":"M Lipsitch","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1128\/CMR.00060-05","article-title":"Tuberculosis chemotherapy: the influence of bacillary stress and damage response pathways on drug efficacy.","volume":"19","author":"DF Warner","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0041-3879(87)80014-4","article-title":"Drug resistance in tuberculosis control.","volume":"68","author":"T Shimao","year":"1987","journal-title":"Tubercle"},{"key":"ref42","first-page":"465","article-title":"Relative Numbers of Resistant Tubercle-Bacilli in Sputa of Patients before and during Treatment with Streptomycin.","volume":"22","author":"MM Pyle","year":"1947","journal-title":"Mayo Clin Proc"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1378\/chest.111.5.1168","article-title":"Noncompliance with directly observed therapy for tuberculosis. Epidemiology and effect on the outcome of treatment.","volume":"111","author":"WJ Burman","year":"1997","journal-title":"Chest"},{"key":"ref44","first-page":"887","article-title":"Determinants of drug-resistant tuberculosis: analysis of 11 countries.","volume":"5","author":"MA Espinal","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0002-9343(96)00402-0","article-title":"Nonadherence in tuberculosis treatment: predictors and consequences in New York City.","volume":"102","author":"A Pablos-Mendez","year":"1997","journal-title":"Am J Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1371\/journal.pmed.0040238","article-title":"Patient adherence to tuberculosis treatment: A systematic review of qualitative research.","volume":"4","author":"SA Munro","year":"2007","journal-title":"Plos Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1128\/JB.181.7.2044-2049.1999","article-title":"Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide.","volume":"181","author":"Y Zhang","year":"1999","journal-title":"J Bacteriol"},{"key":"ref48","first-page":"6","article-title":"The curious characteristics of pyrazinamide: a review.","volume":"7","author":"Y Zhang","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref49","first-page":"519","article-title":"The effect of pulsed exposures to rifampin on the uptake of uridine- 14 C by Mycobacterium tuberculosis.","volume":"105","author":"JM Dickinson","year":"1972","journal-title":"Am Rev Respir Dis"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0272-5231(21)00072-1","article-title":"Bacteriologic basis of short-course chemotherapy for tuberculosis.","volume":"1","author":"J Grosset","year":"1980","journal-title":"Clin Chest Med"},{"key":"ref51","first-page":"327","article-title":"Non-adherence to tuberculosis treatment in the eastern Tarai of Nepal.","volume":"7","author":"DF Wares","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/msb4100133","article-title":"Networks from drug-drug surfaces.","volume":"3","author":"P Yeh","year":"2007","journal-title":"Mol Syst Biol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/msb4100135","article-title":"Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli.","volume":"3","author":"DJ Dwyer","year":"2007","journal-title":"Mol Syst Biol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.cell.2007.06.049","article-title":"A common mechanism of cellular death induced by bactericidal antibiotics.","volume":"130","author":"MA Kohanski","year":"2007","journal-title":"Cell"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2008.09.038","article-title":"Mistranslation of Membrane Proteins and Two-Component System Activation Trigger Antibiotic-Mediated Cell Death.","volume":"135","author":"MA Kohanski","year":"2008","journal-title":"Cell"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"17025","DOI":"10.1073\/pnas.252607699","article-title":"Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics.","volume":"99","author":"EB Goh","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"12833","DOI":"10.1073\/pnas.96.22.12833","article-title":"Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization.","volume":"96","author":"W Wilson","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"12200","DOI":"10.1073\/pnas.0505446102","article-title":"Ancestral antibiotic resistance in Mycobacterium tuberculosis.","volume":"102","author":"RP Morris","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1111\/j.1365-2958.2005.04510.x","article-title":"The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol.","volume":"55","author":"R Colangeli","year":"2005","journal-title":"Mol Microbiol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1371\/journal.ppat.0030087","article-title":"Transcriptional regulation of multi-drug tolerance and antibiotic-induced responses by the histone-like protein Lsr2 in M-tuberculosis.","volume":"3","author":"R Colangeli","year":"2007","journal-title":"Plos Path"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1128\/AAC.43.2.218","article-title":"Exposure to antibiotics induces expression of the Mycobacterium tuberculosis sigF gene: Implications for chemotherapy against mycobacterial persistors.","volume":"43","author":"TM Michele","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"ref62","article-title":"Empirical Model-Building and Response Surfaces.","author":"GEP Box","year":"1987"},{"key":"ref63","first-page":"421-&","article-title":"Strategy of Model Building in Population Biology.","volume":"54","author":"R Levins","year":"1966","journal-title":"Am Sci"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1592\/phco.29.12.1468","article-title":"Treatment of Active Pulmonary Tuberculosis in Adults: Current Standards and Recent Advances Insights from the Society of Infectious Diseases Pharmacists.","volume":"29","author":"RG Hall","year":"2009","journal-title":"Pharmacotherapy"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1462-5822.2008.01133.x","article-title":"Comparative pathogenesis of Mycobacterium marinum and Mycobacterium tuberculosis.","volume":"10","author":"DM Tobin","year":"2008","journal-title":"Cell Microbiol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2011.02.022","article-title":"Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism.","volume":"145","author":"KN Adams","year":"2011","journal-title":"Cell"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1128\/AAC.47.1.106-117.2003","article-title":"In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates.","volume":"47","author":"J Meletiadis","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/jac\/12.6.555","article-title":"Synergy with double and triple antibiotic combinations compared.","volume":"12","author":"MC Berenbaum","year":"1983","journal-title":"J Antimicrob Chemother"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/jac\/dkn554","article-title":"Functional relationship between bacterial cell density and the efficacy of antibiotics.","volume":"63","author":"KI Udekwu","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1128\/AAC.48.10.3670-3676.2004","article-title":"Pharmacodynamic functions: a multiparameter approach to the design of antibiotic treatment regimens.","volume":"48","author":"RR Regoes","year":"2004","journal-title":"Antimicrob Agents Chemother"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1002487","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T19:21:18Z","timestamp":1742325678000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1002487"}},"subtitle":[],"editor":[{"given":"Sarah M.","family":"Fortune","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,1,12]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,1,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1002487","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,12]]}}}